Status:
COMPLETED
Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborating Sponsors:
US Department of Veterans Affairs
Conditions:
Hematologic Diseases
Healthy Volunteers
Eligibility:
All Genders
18+ years
Brief Summary
This research study goal is to analyze the plasma and the cells that make up part of the immune system. We want to learn how the plasma and cells work. These may influence why one person will develop ...
Detailed Description
This research study goal is to analyze the plasma and the cells that make up part of the immune system. These cells, called white cells or leukocytes, are present in blood. We want to learn how these ...
Eligibility Criteria
Inclusion
- Must be able to give blood
- Must be able to give informed consent
- Signed, written informed consent
Exclusion
- Individuals with a history severe anemia, inadequate venous access, severe blood or coagulation disorders.
- Pregnant women are excluded because it is a unique immunotolerant state and will alter the profile of immunomodulatory molecules.
Key Trial Info
Start Date :
March 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 14 2021
Estimated Enrollment :
512 Patients enrolled
Trial Details
Trial ID
NCT00223483
Start Date
March 1 2005
End Date
July 14 2021
Last Update
July 16 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Veterans Affairs, South Texas Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital Division
San Antonio, Texas, United States, 78229
2
The University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States, 78229